Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Weiss, Walter R ^a   Jiang, Chengyong George ^a,b  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b BOOZ ALLEN HAMILTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; CHLOROQUINE; IMMUNOGLOBULIN G; MALARIA VACCINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CM-T807; UNCLASSIFIED DRUG; GAMMA INTERFERON; LIVE VACCINE;

ADULT ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNIZATION; LYMPHOCYTE SUBPOPULATION; MACACA MULATTA; NONHUMAN; PLASMODIUM KNOWLESI; PLASMODIUM KNOWLESI MALARIA; PROTECTION; RHESUS MONKEY; SPOROZOITE; ANIMAL; BLOOD; CASE CONTROL STUDY; FLOW CYTOMETRY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LIVER; MALARIA; MOUSE; PARASITOLOGY; VACCINATION;

ANIMALIA; BACTERIA (MICROORGANISMS); MACACA MULATTA; MUS; PLASMODIUM KNOWLESI; PRIMATES;

ANIMALS; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; IMMUNIZATION; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; LIVER; MACACA MULATTA; MALARIA; MALARIA VACCINES; MICE; PLASMODIUM KNOWLESI; SPOROZOITES; VACCINATION; VACCINES, ATTENUATED;

EID: 84857066230     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031247     Document Type: Article

References (27)

1. Nussenzweig RS, Vanderberg J, Most H, Orton C, (1967) Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei. Nature 216: 160-162.
2. Mueller AK, Labaied M, Kappe SH, Matuschewski K, (2005) Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 433: 164-167.
3. Gwadz RW, Cochrane AH, Nussenzweig V, Nussenzweig RS, (1979) Preliminary studies on vaccination of rhesus monkeys with irradiated sporozoites of Plasmodium knowlesi and characterization of surface antigens of these parasites. Bull World Health Organ 57 (Suppl 1): 165-173.
4. Hoffman SL, Goh LM, Luke TC, Schneider I, Le TP, et al. (2002) Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis 185: 1155-1164.
5. Hoffman SL, Billingsley PF, James E, Richman A, Loyevsky M, et al. (2010) Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria. Hum Vaccin 6: 97-106.
6. Schofield L, Villaquiran J, Ferreira A, Schellekens H, Nussenzweig R, et al. (1987) Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 330: 664-666.
7. Weiss WR, Sedegah M, Beaudoin RL, Miller LH, Good MF, (1988) CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc Natl Acad Sci U S A 85: 573-576.
8. Aggarwal A, Kumar S, Jaffe R, Hone D, Gross M, et al. (1991) Oral Salmonella: malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells. JExpMed 172: 1083-1090.
9. Schmitz JE, Simon MA, Kuroda MJ, Lifton MA, Ollert MW, et al. (1999) A nonhuman primate model for the selective elimination of CD8+ lymphocytes using a mouse-human chimeric monoclonal antibody. Am J Pathol 154: 1923-1932.
10. Jiang G, Charoenvit Y, Moreno A, Baraceros MF, Banania G, et al. (2007) Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunization. Malar J 6: 135.
11. Charoenvit Y, Leef MF, Yuan LF, Sedegah M, Beaudoin RL, (1987) Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens. Infect Immun 55: 604-608.
12. Mueller AK, Deckert M, Heiss K, Goetz K, Matuschewski K, et al. (2007) Genetically attenuated Plasmodium berghei liver stages persist and elicit sterile protection primarily via CD8 T cells. Am J Pathol 171: 107-115.
13. Overstreet MG, Cockburn IA, Chen YC, Zavala F, (2008) Protective CD8 T cells against Plasmodium liver stages: immunobiology of an 'unnatural' immune response. Immunol Rev 225: 272-283.
14. Vanderberg J, Mueller AK, Heiss K, Goetz K, Matuschewski K, et al. (2007) Assessment of antibody protection against malaria sporozoites must be done by mosquito injection of sporozoites. Am J Pathol 171: 1405-1406; author reply 1406.
15. Belmonte M, Jones TR, Lu M, Arcilla R, Smalls T, et al. (2003) The infectivity of Plasmodium yoelii in different strains of mice. J Parasitol 89: 602-603.
16. Jaffe RI, Lowell GH, Gordon DM, (1990) Differences in susceptibility among mouse strains to infection with Plasmodium berghei (ANKA clone) sporozoites and its relationship to protection by gamma-irradiated sporozoites. Am J Trop Med Hyg 42: 309-313.
17. Weiss WR, Good MF, Hollingdale MR, Miller LH, Berzofsky JA, (1989) Genetic control of immunity to Plasmodium yoelii sporozoites. J Immunol 143: 4263-4266.
18. Gruner AC, Mauduit M, Tewari R, Romero JF, Depinay N, et al. (2007) Sterile protection against malaria is independent of immune responses to the circumsporozoite protein. PLoS One 2: e1371.
19. Kumar KA, Sano G, Boscardin S, Nussenzweig RS, Nussenzweig MC, et al. (2006) The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature 444: 937-940.
20. Mauduit M, Gruner AC, Tewari R, Depinay N, Kayibanda M, et al. (2009) A role for immune responses against non-CS components in the cross-species protection induced by immunization with irradiated malaria sporozoites. PLoS One 4: e7717.
21. Mauduit M, Tewari R, Depinay N, Kayibanda M, Lallemand E, et al. (2010) Minimal role for the circumsporozoite protein in the induction of sterile immunity by vaccination with live rodent malaria sporozoites. Infect Immun 78: 2182-2188.
22. Silvie O, Franetich JF, Charrin S, Mueller MS, Siau A, et al. (2004) A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites. J Biol Chem 279: 9490-9496.
23. Weiss WR, Kumar A, Jiang G, Williams J, Bostick A, et al. (2007) Protection of rhesus monkeys by a DNA prime/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigens. PLoS One 2: e1063.
24. Doolan DL, Hoffman SL, Southwood S, Wentworth PA, Sidney J, et al. (1997) Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity 7: 97-112.
25. Malik A, Egan JE, Houghten RA, Sadoff JC, Hoffman SL, (1991) Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. Proc Natl Acad Sci U S A 88: 3300-3304.
26. Epstein JE, Tewari K, Lyke KE, Sim BK, Billingsley PF, et al. (2011) Live Attenuated Malaria Vaccine Designed to Protect through Hepatic CD8+ T Cell Immunity. Science.
27. Rodriguez A, Mintardjo R, Tax D, Gillissen G, Custers J, et al. (2009) Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys. Vaccine 27: 6226-6233.